Vulnerability in Gbgplc Acuant Acufill Sdk

CVE-2022-48221

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. Multiple MSI's get executed out of a standard-user writable directory. Through a race condition and OpLock manipulation, these files can be overwritten by a standard user. They then get executed by the elevated installer. This gives a standard user full SYSTEM code execution (elevation of privileges).

Vulnerability class: Race Condition

Published · last modified .

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.005 (41.0th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 41st percentile — 41.0% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-48221: held from 0.005 to 0.005.

EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-48221?
CVE-2022-48221 is a high-severity vulnerability in Gbgplc Acuant Acufill Sdk, classified under Concurrent Execution using Shared Resource with Improper Synchronization (Race Condition). CVSS score: 7.5/10. Published 2023-04-04.
How severe is CVE-2022-48221?
High severity. CVSS v3 base score is 7.5 out of 10.